Search

Your search keyword '"Hochman, Judith S."' showing total 1,645 results

Search Constraints

Start Over You searched for: Author "Hochman, Judith S." Remove constraint Author: "Hochman, Judith S."
1,645 results on '"Hochman, Judith S."'

Search Results

3. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

5. Mentoring Underrepresented Minority Physician-Scientists to Success

7. Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life

8. Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD

9. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19

11. CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial

14. Go Red for Women Strategically Focused Research Network: Summary of Findings and Network Outcomes

15. Myocardial Infarction in the ISCHEMIA Trial

16. Impact of Complete Revascularization in the ISCHEMIA Trial

17. Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial

18. Abstract 14153: P2Y12 Inhibitors and Quality of Life Outcomes in Critically Ill Patients Hospitalized for COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a Randomized Clinical Trial

19. Abstract 13200: Changes in Thrombi-Inflammatory Biomarkers Associated With Therapeutic Heparin in Non-Critically Ill Patients Hospitalized With COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a and ATTACC Randomized Clinical Trial

20. Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial

21. From Stigma to Validation: A Qualitative Assessment of a Novel National Program to Improve Retention of Physician-Scientists with Caregiving Responsibilities

22. Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations JACC State-of-the-Art Review

23. The Most Valuable Resource Is Time: Insights From a Novel National Program to Improve Retention of Physician-Scientists With Caregiving Responsibilities.

25. Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial

27. Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial

28. Cardiometabolic Comorbidity Burden and Circulating Biomarkers in Patients with Chronic Coronary Disease in the ISCHEMIA Trials

29. Comparative Prognostic Utility of Coronary CT and Invasive Angiography

30. ISCHEMIA-EXTEND studies: Rationale and design

31. The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction Insights From the ACTION Registry

33. Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial

34. Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial

35. Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia

36. American Heart Association Cardiogenic Shock Registry: Design and Implementation.

37. Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

38. An Innovative Program to Support Gender Equity and Success in Academic Medicine: Early Experiences From the Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists.

39. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

40. Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial

41. Abstract 14850: Effect of Therapeutic-Dose Heparin on Acute Kidney Injury in Non-Critically Ill Hospitalized Patients With Covid-19: The Activ4a and Attac Randomized Trial

47. Outcomes of Participants with Diabetes in the ISCHEMIA Trials

48. Body Mass Index and Clinical and Health Status Outcomes in Chronic Coronary Disease and Advanced Kidney Disease in the ISCHEMIA-CKD Trial

49. Psychosocial Factors of Women Presenting With Myocardial Infarction With or Without Obstructive Coronary Arteries

Catalog

Books, media, physical & digital resources